Explore the words cloud of the FILODIAG project. It provides you a very rough idea of what is the project "FILODIAG" about.
The following table provides information about the project.
Coordinator |
GNA BIOSOLUTIONS GMBH
Organization address contact info |
Coordinator Country | Germany [DE] |
Project website | http://www.filodiag.eu |
Total cost | 2˙260˙105 € |
EC max contribution | 2˙260˙105 € (100%) |
Programme |
1. H2020-EU.3.1.7. (Innovative Medicines Initiative 2 (IMI2)) |
Code Call | H2020-JTI-IMI2-2014-02-single-stage |
Funding Scheme | IMI2-RIA |
Starting year | 2015 |
Duration (year-month-day) | from 2015-02-01 to 2017-12-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | GNA BIOSOLUTIONS GMBH | DE (Martinsried) | coordinator | 1˙461˙750.00 |
2 | ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO | IT (ROMA) | participant | 404˙105.00 |
3 | MENDELOVA UNIVERZITA V BRNE | CZ (BRNO SEVER) | participant | 381˙750.00 |
4 | EMERGENCY LIFE SUPPORT FOR CIVILIAN WAR VICTIMS ONG ONLUS | IT (MILANO) | participant | 12˙500.00 |
There is an urgent need for fast and accurate diagnostic tests in the current Ebola crisis. The rapid diagnosis of EVD during early and late stage of infection is a decisive step for risk assessment and for guidance to physicians to take the necessary decisions to limit the spread of the infection, and to safely nurse the infected patients. While fast and easy-to-use tests usually rely on immuno-diagnostic approaches, they typically lack high sensitivity and specificity. The gold standard for accurate diagnostics, (Real-Time) PCR, however, is limited in terms of processing time, high costs, and in most cases also in terms of ease of use and the need of special laboratory facilities.
The aim of this project is to provide an ultra-fast and accurate molecular diagnostic instrument that can perform a molecular Ebola test within 10-15 minutes. Patients, suspected of Ebola Virus Disease (EBD), due to fever and/or other clinical signs, could be rapidly and accurately tested at the Point-of-Care by withdrawal of blood, or less invasive fluids, such as saliva or urine.
The core technology of this proposal is based on laser-heated nanoparticles (Laser PCR), overcoming the time-limiting step of heating and cooling the reaction sample in conventional PCR allowing for drastically reduced turn-around times. The project partners (GNA, INMI, MUB, EMG) have the competence to integrate sample preparation with virus-binding magnetic particles, ultra-fast molecular diagnostics with Laser PCR, test the system in a biosafety level 4 laboratory in Rome, Italy, and thoroughly conduct field testing in a medical care centre in West Africa (Sierra Leone).
A tentative Ebola Laser PCR assay has already been set up, detecting 10 target copies of synthetic DNA oligos, corresponding to the Ebola genome sequence, in less than 12 minutes. The FILODIAG project will deliver a potentially multiplexed diagnostic system fast enough for point-of need testing of incoming patients at low-resource
Final report | Websites, patent fillings, videos etc. | 2019-10-08 14:22:42 |
Patent application for nanomaghemite particles for virus model | Websites, patent fillings, videos etc. | 2019-05-30 17:11:07 |
Performance evaluation of each integration step of the test platform | Documents, reports | 2019-04-25 22:12:48 |
Patent application for nanomaghemite particles for Ebola | Websites, patent fillings, videos etc. | 2019-04-25 22:12:47 |
Providing one improved Pharos instrument | Demonstrators, pilots, prototypes | 2019-04-25 22:12:47 |
Higher process integration | Websites, patent fillings, videos etc. | 2019-04-25 22:12:47 |
Take a look to the deliverables list in detail: detailed list of FILODIAG deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2016 |
Rebuffo-Scheer et al. Rapid detection of cDNA from Ebola virus isolate by Laser PCR published pages: , ISSN: , DOI: |
ECCMID 2016, Poster Presentation 3838 | 2019-05-15 |
2015 |
Krejcova et al. Beads-based automatic pcr for detection of lentivirus with Ebola gp protein published pages: , ISSN: , DOI: |
Targeting Ebola Paris 2015, Poster Presentation 48 | 2019-05-15 |
2015 |
Kizek et al. Ebola gp protein fragments and their basic characterisati on provided by mass spectrometry, spectroscopy, chromatogra phy and electrochemi stry published pages: , ISSN: , DOI: |
Targeting Ebola Paris 2015, Poster Presentation 45 | 2019-05-15 |
2015 |
Michalek P. et al. The preparation and characterisation of lentivirus with Ebola gp protein published pages: , ISSN: , DOI: |
Targeting Ebola Paris 2015, Poster Presentation 60 | 2019-05-15 |
2017 |
Rebuffo-Scheer et al. Rapid One-Step RT-Laser PCR® detection of Ebola Virus: analytical performance evaluation and comparison with the commercially available RT-PCR kit RealStar® FilovirusScreen published pages: , ISSN: , DOI: |
ESCV 2017, poster presentation | 2019-04-25 |
2017 |
INMI TEST diagnostico per EBOLA: ricercatori INMI in missione in Sierra Leone published pages: , ISSN: , DOI: |
INMI Spallanzani Informa | 2019-04-25 |
2018 |
INMI Validazione di un nuovo test Diagnostico: “Ebola, ricercatori dello Spallanzani†published pages: , ISSN: , DOI: |
La Sanità del Lazio N°16, March 2018 | 2019-04-25 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "FILODIAG" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "FILODIAG" are provided by the European Opendata Portal: CORDIS opendata.
Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors
Read More